Evidence map›Paper›PMID 41324649›Full record

ArticleCellular and molecular life sciences : CMLS2025

Local accumulation of very long-chain PUFA in plexiform layers associates with retinal dysfunction in a mouse model of peroxisomal ACBD5-deficiency.

Julia Merz, Elisabeth Müller, Warda Darwisch, Richard Fairless, Yixin Wang, Silke Vorwald, Sharau Darwisch, E Ronald Curticean, Feng Shao, Irene Wacker and 11 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Julia MerzInstitute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Elisabeth MüllerCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.
Warda DarwischInstitute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Richard FairlessDepartment of Neurology, University Clinic Heidelberg, Heidelberg, Germany.
Yixin WangExperimental Pharmacology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Silke VorwaldInstitute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Sharau DarwischInstitute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
E Ronald CurticeanBioQuant, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Feng ShaoExperimental Pharmacology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Irene WackerBioQuant, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Rasmus R SchröderBioQuant, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Claudia PitzerInterdisciplinary Neurobehavioral Core, INBC, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.
Christian SchultzInstitute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Jan-Bert van KlinkenDepartment of Laboratory Medicine and Pediatrics, Laboratory Genetic Metabolic Diseases, Amsterdam UMC location University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.
Frederic M VazDepartment of Laboratory Medicine and Pediatrics, Laboratory Genetic Metabolic Diseases, Amsterdam UMC location University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.
Frank KratzerDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Hospital Heidelberg Center of Pediatric and Adolescent Medicine, Heidelberg, Germany.
Kathrin SchwarzDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Hospital Heidelberg Center of Pediatric and Adolescent Medicine, Heidelberg, Germany.
Jürgen G OkunDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Hospital Heidelberg Center of Pediatric and Adolescent Medicine, Heidelberg, Germany.
Yuxi FengExperimental Pharmacology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Carsten HopfMannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Markus IslingerInstitute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany. markus.islinger@medma.uni-heidelberg.de.ORCID http://orcid.org/0000-0001-8881-0902

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients deficient in the peroxisomal membrane protein ACBD5 regularly exhibit a dystrophy of the retina along with decline in visual acuity. Despite the prevalent retinal phenotype, information on the pathogenesis of the retinodystrophy is limited. To gain insight into the cellular, subcellular and molecular alterations occurring in the retina, we analyzed an ACBD5-deficient mouse model by immunofluorescence microscopy, electron microscopy, full-field electroretinography (ffERG) and as well as analytical and spatial mass spectrometry (MS)-based lipidomics techniques. Histological results implied that ACBD5-deficient mice exhibit a moderate degeneration of photoreceptor, bipolar, ganglion and retinal pigment epithelial cells accompanied, however, by a prominent activation of astroglia and microglia. Reduced a- and b-wave amplitudes from ffERG point to a severe functional dysregulation of retinal signal transduction with a focus at the level of the information-processing cell of the inner retina. At the lipidome level, very long-chain polyunsaturated fatty acids (VLC-PUFA) accumulated in phosphatidylcholines from retina homogenates, most likely disrupted by a decline in peroxisome functions. Remarkably, as revealed by MALDI MS imaging, these lipidome changes affected neither the whole retina nor the photoreceptor outer segments (POS), where VLC-PUFAs display the highest concentration in phospholipids of POS membrane discs. In contrast, VLC-PUFAs in ACBD5-deficient mice consistently accumulated in the inner retinal region from the outer (OPL) to inner plexiform layer (IPL). In line with VLC-PUFA-accumulations, photoreceptor ribbon synapses in the OPL showed morphological signs of degeneration on the ultrastructural level. Hence, peroxisomal dysfunction appears to affect cell type-specific lipid homeostasis, thereby disrupting local retinal membrane physiology leading to a severe neuroinflammation of the ACBD5-deficient mouse retina.

Indexed as

Fatty Acids, UnsaturatedMembrane ProteinsPeroxisomal DisordersRetinaAnimalsDisease Models, AnimalElectroretinographyLipidomicsMiceMice, Inbred C57BLMice, KnockoutPeroxisomesFatty Acids, UnsaturatedMembrane ProteinsMetabolic disordersPeroxisomesRDLKD (ACBD5-deficiency)RetinodystrophyVery long-chain fatty acids (VLCFA)

Identifiers

PMID41324649
PMCPMC12775220

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.